Invicta Diagnostic IPO opens for subscription on December 1, 2025, and will close on December 3, 2025. The IPO is a Book Built Issue, and the company plans to raise ₹28.12 crores through a fresh issue. The price band has been set between ₹80 and ₹85 per share. The IPO allotment is scheduled for December 4, while the listing will take place on NSE SME on December 8, 2025.
The company has shown steady financial growth, reporting revenue of ₹30.18 crores in 2025, almost double its 2024 performance. With a profit of ₹4.93 crores in FY2025 and strong operational margins, investors may consider this IPO for long-term potential.
Contents
Invicta Diagnostic IPO Details
| Detail | Information |
|---|---|
| IPO Open Date | December 1, 2025 |
| IPO Close Date | December 3, 2025 |
| Face Value | ₹10 per equity share |
| IPO Price Band | ₹80 to ₹85 per share |
| Issue Size | Approx ₹28.12 crores |
| Fresh Issue | Approx ₹28.12 crores |
| Issue Type | Book Built Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus | View PDF |
| RHP Draft Prospectus | View PDF |
Invicta Diagnostic IPO
Open: 1-3 Dec
Issue Size: ₹28.12 Cr.
Objective: To fund new diagnostic centres and buy medical equipment across Maharashtra.
Exchange: NSE SME
Invicta Diagnostic IPO GMP Today
The Invicta Diagnostic IPO GMP (Grey Market Premium) has not started yet, as trading activity in the grey market will likely pick up closer to the listing week. Since the company’s SME IPO opens on 1 December 2025, investors are watching the early market sentiment to understand possible listing gains.
Invicta Diagnostic aims to raise ₹28.12 crore, with a price band of ₹80–₹85 and a lot size of 3,200 shares. For now, the GMP remains unquoted, so it is best to wait for fresh updates once grey market bidders begin placing informal trades.
As soon as the premium starts reflecting, it will give a clearer picture of demand and expected upside for retail and HNI investors. Stay tuned for day-wise GMP trends and Kostak updates as the IPO window progresses.
Invicta Diagnostic IPO Review
Invicta Diagnostic has delivered consistent growth in revenue and profitability over the years. With expanding operations, strong PAT margins, and a low debt-to-equity structure, the company appears fundamentally stable.
The expansion of diagnostic centres across Maharashtra may support long-term scalability. Investors looking for growth-oriented SMEs may find this IPO suitable for long-term holding.
Invicta Diagnostic IPO Market Lot
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 3,200 | ₹2,72,000 |
| Retail Maximum | 2 | 3,200 | ₹2,72,000 |
| S-HNI Minimum | 3 | 4,800 | ₹4,08,000 |
| S-HNI Maximum | 7 | 11,200 | ₹9,52,000 |
| B-HNI Minimum | 8 | 12,800 | ₹10,88,000 |
Invicta Diagnostic IPO Reservation
| Investor Category | Shares Offered | % Shares |
|---|---|---|
| Anchor Investor | – | – |
| QIB (Ex. Anchor) | – | 50% |
| NII Shares Offered | – | 15% |
| Retail Shares Offered | – | 35% |
- Also Read: Clear Secured IPO, Logiciel Solutions IPO
Invicta Diagnostic IPO Anchor Investors
| Anchor Detail | Information |
|---|---|
| Anchor Bidding Date | November 28, 2025 |
| Anchor Investors List | View PDF |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| Lock-in period end date (50% – 30 days) | January 4, 2025 |
| Lock-in period end date (50% – 90 days) | March 3, 2025 |
Invicta Diagnostic IPO Dates
| Event | Date |
|---|---|
| IPO Open Date | December 1, 2025 |
| IPO Close Date | December 3, 2025 |
| Basis of Allotment | December 4, 2025 |
| Refunds | December 5, 2025 |
| Credit to Demat | December 5, 2025 |
| Listing Date | December 8, 2025 |
| Bidding Cut-off Time | December 3, 2025 – 5 PM |
Promoters and Shareholding Pattern
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 92,63,173 | 91.89% |
| Promoter Holding Post Issue | 1,25,71,973 | –% |
Objects of the Issue
The company plans to utilise the proceeds primarily to fund capital expenditure for purchasing medical equipment and establishing five new diagnostic centres across Maharashtra. The remaining funds will be used for general corporate purposes.
About Invicta Diagnostic Company
Invicta Diagnostic is a growing healthcare and pathology services provider offering a wide range of diagnostic tests across Maharashtra. The company focuses on accurate reporting, advanced technology, and affordable services.
With plans to open new centres, Invicta aims to expand its footprint and strengthen its presence in the diagnostic industry.
Invicta Diagnostic Company Financial Report in (₹ Cr.)
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2024 | 15.90 | 10.78 | 3.81 | 15.89 |
| 2025 | 30.18 | 23.62 | 4.93 | 21.22 |
| September 2025 | 17.08 | 11.65 | 4.08 | 34.90 |
Invicta Diagnostic IPO Valuation – FY2025
| KPI | Values |
|---|---|
| ROE | 44.28% |
| ROCE | 42.00% |
| EBITDA Margin | 30.57% |
| PAT Margin | 16.38% |
| Debt to Equity Ratio | 0.26 |
| EPS (Basic) | ₹5.86 |
| PE Ratio | N/A |
| RoNW | 36.25% |
| NAV | ₹16.15 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Ltd | 13.95 | 71.90 | 17.99% | 77.86 | – |
| Krsnaa Diagnostics Ltd | 24.04 | 29.58 | 8.79% | 272.54 | – |
IPO Lead Manager
Socradamus Capital Pvt. Ltd.
Company Address
| Detail | Information |
|---|---|
| Company Name | Invicta Diagnostic Ltd. |
| Address | 1 GF, Plot 217, Ambavat Bhavan, N.M Joshi Marg, Delisle Road |
| City | Mumbai |
| State | Maharashtra |
| Pincode | 400013 |
| Phone | 022–4971 0036 |
| investors@pcdiagnostics.in | |
| Website | https://www.pcdiagnostics.in/ |
IPO Registrar
| Detail | Information |
|---|---|
| Registrar | Bigshare Services Pvt. Ltd. |
| Phone | +91-22-6263 8200 |
| ipo@bigshareonline.com | |
| Website | https://ipo.bigshareonline.com/IPO_Status.html |
Invicta Diagnostic IPO FAQs
What is Invicta Diagnostic IPO?
It is an SME IPO worth ₹28.12 crores, priced between ₹80 and ₹85 per share, and will list on NSE SME.
When does the IPO open?
The IPO opens on December 1, 2025 and closes on December 3, 2025.
What is the investor allocation?
QIB gets 50%, NII gets 15%, and retail investors get 35%.
How can I apply for the IPO?
You can apply via ASBA through your bank or UPI through your stockbroker, both online or offline.
What is the issue size?
The total issue size is ₹28.12 crores.
What is the lot size?
The minimum lot size is 3,200 shares, amounting to ₹2,72,000.
When is the listing?
The shares will list on NSE SME on December 8, 2025.
What is the allotment date?
The allotment date is December 4, 2025.
Expert Comment
Invicta Diagnostic shows healthy financial momentum and efficient operations, supported by high ROE and strong margins. With expansion planned across Maharashtra, the company is positioning itself for scalable growth.
While SME IPOs carry moderate risk, the fundamentals appear stable enough for investors seeking long-term exposure in the diagnostic services sector.
